cyber, your CLDX posts were excellent. Do you know how long it typically takes to complete Phase III & if Phase II tests were successful, do you know how & why Phase III might not be?
Also, how long does it take to get a product like CLDX's to market domestically & internationally?
I am anxious to hear Oakes's presentation in LA on Dec.4th as it says he will outline their goals & objectives
for 2014. So much has happened lately, it'll be interesting to see how close we are to a revenue stream.
Thanks for all your input & help.
I wouldn't be looking at the revenue stream of CLDX..
the good news for CLDX was just another confirmation of the importance of KLH..
Look at the upcoming conference to maybe shed a little more light on what kind of catalysts
we will see in 2014..
just like we are looking forward (phase 3 trials can take a long time).. imo big pharma is also looking forward.. and the more KLH is validated.. the bigger chance for significant news imo (order contracts/partnerships even potential buyout)..
I personally wouldn't short CLDX however, I would much rather own SBOTF.. just because again,
this is ONLY ONE of the many, many catalysts for sbotf.